BOEING CO/THE (BCO.DE) Stock Fundamental Analysis

FRA:BCO • US0970231058

204.6 EUR
+2.2 (+1.09%)
Last: Feb 13, 2026, 05:29 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to BCO. BCO was compared to 54 industry peers in the Aerospace & Defense industry. BCO may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, BCO is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year BCO has reported negative net income.
  • In the past year BCO had a positive cash flow from operations.
  • In the past 5 years BCO reported 4 times negative net income.
  • The reported operating cash flow has been mixed in the past 5 years: BCO reported negative operating cash flow in multiple years.
BCO.DE Yearly Net Income VS EBIT VS OCF VS FCFBCO.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B -10B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 1.12%, BCO is doing worse than 68.52% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 34.65%, BCO belongs to the top of the industry, outperforming 90.74% of the companies in the same industry.
Industry RankSector Rank
ROA 1.12%
ROE 34.65%
ROIC N/A
ROA(3y)-2.7%
ROA(5y)-2.95%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BCO.DE Yearly ROA, ROE, ROICBCO.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1K 2K 3K

1.3 Margins

  • BCO has a Profit Margin of 2.11%. This is in the lower half of the industry: BCO underperforms 66.67% of its industry peers.
  • BCO has a Gross Margin of 4.79%. This is amonst the worse of the industry: BCO underperforms 83.33% of its industry peers.
  • BCO's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 2.11%
GM 4.79%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.29%
GM growth 5YN/A
BCO.DE Yearly Profit, Operating, Gross MarginsBCO.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20

1

2. Health

2.1 Basic Checks

  • BCO does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for BCO has been increased compared to 1 year ago.
  • BCO has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, BCO has an improved debt to assets ratio.
BCO.DE Yearly Shares OutstandingBCO.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
BCO.DE Yearly Total Debt VS Total AssetsBCO.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B 150B

2.2 Solvency

  • Based on the Altman-Z score of 1.39, we must say that BCO is in the distress zone and has some risk of bankruptcy.
  • BCO has a worse Altman-Z score (1.39) than 79.63% of its industry peers.
  • BCO has a Debt/Equity ratio of 8.37. This is a high value indicating a heavy dependency on external financing.
  • BCO has a Debt to Equity ratio of 8.37. This is amonst the worse of the industry: BCO underperforms 88.89% of its industry peers.
Industry RankSector Rank
Debt/Equity 8.37
Debt/FCF N/A
Altman-Z 1.39
ROIC/WACCN/A
WACC9.66%
BCO.DE Yearly LT Debt VS Equity VS FCFBCO.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20B 40B 60B

2.3 Liquidity

  • BCO has a Current Ratio of 1.19. This is a normal value and indicates that BCO is financially healthy and should not expect problems in meeting its short term obligations.
  • BCO's Current ratio of 1.19 is in line compared to the rest of the industry. BCO outperforms 51.85% of its industry peers.
  • A Quick Ratio of 0.40 indicates that BCO may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.40, BCO is doing worse than 88.89% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.19
Quick Ratio 0.4
BCO.DE Yearly Current Assets VS Current LiabilitesBCO.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

6

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 49.34% over the past year.
  • BCO shows a strong growth in Revenue. In the last year, the Revenue has grown by 34.50%.
  • BCO shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.81% yearly.
EPS 1Y (TTM)49.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.02%
Revenue 1Y (TTM)34.5%
Revenue growth 3Y10.33%
Revenue growth 5Y8.81%
Sales Q2Q%57.12%

3.2 Future

  • The Earnings Per Share is expected to grow by 26.74% on average over the next years. This is a very strong growth
  • BCO is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.94% yearly.
EPS Next Y101.96%
EPS Next 2Y57.38%
EPS Next 3Y42.54%
EPS Next 5Y26.74%
Revenue Next Year9.4%
Revenue Next 2Y12.12%
Revenue Next 3Y11.24%
Revenue Next 5Y9.94%

3.3 Evolution

  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
BCO.DE Yearly Revenue VS EstimatesBCO.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 50B 100B 150B
BCO.DE Yearly EPS VS EstimatesBCO.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 10 -10 -20

1

4. Valuation

4.1 Price/Earnings Ratio

  • BCO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Based on the Price/Forward Earnings ratio of 1201.74, the valuation of BCO can be described as expensive.
  • Based on the Price/Forward Earnings ratio, BCO is valued expensively inside the industry as 81.48% of the companies are valued cheaper.
  • When comparing the Price/Forward Earnings ratio of BCO to the average of the S&P500 Index (27.69), we can say BCO is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 1201.74
BCO.DE Price Earnings VS Forward Price EarningsBCO.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 200 400 600 800 1K

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BCO.DE Per share dataBCO.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • BCO's earnings are expected to grow with 42.54% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y57.38%
EPS Next 3Y42.54%

0

5. Dividend

5.1 Amount

  • No dividends for BCO!.
Industry RankSector Rank
Dividend Yield 0%

BOEING CO/THE

FRA:BCO (2/13/2026, 5:29:15 PM)

204.6

+2.2 (+1.09%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)01-27
Earnings (Next)04-21
Inst Owners71.79%
Inst Owner ChangeN/A
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap155.52B
Revenue(TTM)89.46B
Net Income(TTM)1.89B
Analysts83.78
Price Target235.53 (15.12%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0.37
Dividend Growth(5Y)-36.84%
DP17.51%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-118.5%
Min EPS beat(2)-179.06%
Max EPS beat(2)-57.93%
EPS beat(4)2
Avg EPS beat(4)-38.78%
Min EPS beat(4)-179.06%
Max EPS beat(4)63.2%
EPS beat(8)4
Avg EPS beat(8)-30.95%
EPS beat(12)6
Avg EPS beat(12)-17.74%
EPS beat(16)6
Avg EPS beat(16)-664.18%
Revenue beat(2)2
Avg Revenue beat(2)2.86%
Min Revenue beat(2)2.82%
Max Revenue beat(2)2.89%
Revenue beat(4)3
Avg Revenue beat(4)1.03%
Min Revenue beat(4)-2.69%
Max Revenue beat(4)2.89%
Revenue beat(8)3
Avg Revenue beat(8)-1.65%
Revenue beat(12)5
Avg Revenue beat(12)-0.94%
Revenue beat(16)5
Avg Revenue beat(16)-3.25%
PT rev (1m)6.97%
PT rev (3m)3.85%
EPS NQ rev (1m)-1413.16%
EPS NQ rev (3m)-198.24%
EPS NY rev (1m)-89.85%
EPS NY rev (3m)-93.73%
Revenue NQ rev (1m)-2.6%
Revenue NQ rev (3m)-2.68%
Revenue NY rev (1m)-0.24%
Revenue NY rev (3m)-0.57%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 1201.74
P/S 2.06
P/FCF N/A
P/OCF 173.39
P/B 33.86
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-8.69
EYN/A
EPS(NY)0.17
Fwd EY0.08%
FCF(TTM)-2.09
FCFYN/A
OCF(TTM)1.18
OCFY0.58%
SpS99.12
BVpS6.04
TBVpS-14.83
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 1.12%
ROE 34.65%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 2.11%
GM 4.79%
FCFM N/A
ROA(3y)-2.7%
ROA(5y)-2.95%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.29%
GM growth 5YN/A
F-Score6
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 8.37
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 151.1%
Cap/Sales 3.3%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.19
Quick Ratio 0.4
Altman-Z 1.39
F-Score6
WACC9.66%
ROIC/WACCN/A
Cap/Depr(3y)119.8%
Cap/Depr(5y)93.37%
Cap/Sales(3y)2.92%
Cap/Sales(5y)2.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)49.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.02%
EPS Next Y101.96%
EPS Next 2Y57.38%
EPS Next 3Y42.54%
EPS Next 5Y26.74%
Revenue 1Y (TTM)34.5%
Revenue growth 3Y10.33%
Revenue growth 5Y8.81%
Sales Q2Q%57.12%
Revenue Next Year9.4%
Revenue Next 2Y12.12%
Revenue Next 3Y11.24%
Revenue Next 5Y9.94%
EBIT growth 1Y49.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year279.12%
EBIT Next 3Y74.28%
EBIT Next 5Y46.92%
FCF growth 1Y86.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y108.82%
OCF growth 3Y-32.82%
OCF growth 5YN/A

BOEING CO/THE / BCO.DE FAQ

Can you provide the ChartMill fundamental rating for BOEING CO/THE?

ChartMill assigns a fundamental rating of 2 / 10 to BCO.DE.


What is the valuation status for BCO stock?

ChartMill assigns a valuation rating of 1 / 10 to BOEING CO/THE (BCO.DE). This can be considered as Overvalued.


What is the profitability of BCO stock?

BOEING CO/THE (BCO.DE) has a profitability rating of 1 / 10.


Can you provide the financial health for BCO stock?

The financial health rating of BOEING CO/THE (BCO.DE) is 1 / 10.


Can you provide the dividend sustainability for BCO stock?

The dividend rating of BOEING CO/THE (BCO.DE) is 0 / 10 and the dividend payout ratio is 17.51%.